November 9th 2024
Adam E. Singer, MD, PhD, discusses currently available combination treatment regimens for the first-line treatment of patients with renal cell carcinoma.
September 23rd 2024
Adam Singer, MD, PhD, discusses the lack of clinical benefit for sequential immunotherapy in advanced renal cell carcinoma.
November 1st 2023
Neutropenic fever, a commonly occurring and potentially serious chemotherapy complication, requires careful monitoring and close observation.